To evaluate whether tofogliflozin directly inhibits the growth of HCC cells, we examined the expression levels of SGLT2 protein in four human HCC cell lines and Hc normal human hepatocytes [29, 30] using western blot analysis and performed cell proliferation assays in these cells. Here, SLC5A2 is linked to hepatocellular carcinoma.